| 中文名称 | 重酒石酸去甲肾上腺素 |
|---|---|
| 中文别名 | 重酒石酸去甲肾上腺素;L-去甲肾上腺素酒石酸氢盐;酒石酸去甲肾上腺素;盐酸胺碘酮;正肾素;重酒石酸去甲肾上腺素标准品(JP);(R)-4-(2-氨基-1-羟基乙基)-1,2-苯二酚重酒石酸盐一水合物 |
| 英文名称 | (R)-(-)-norepinephrine L-bitartrate monohydrate, |
| 英文别名 | (R)-(-)-norepinephrine L-bitartrate monohydrate,;(R)-()-Norepinephrine L-bitartrate monohydrate;norepinephrine hydrogen tartrate monohydrate;L-Noradrenaline bitartrate;norepinephrine bitartrate monohydrate*200 mg per;Noradrenaline Bitartrate;Norepinephrine Bitartrate;(-)-arterenol bitartrate hydrate;L-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol bitartrate;L-Noradrenaline bitartrate monohydrate;L-(-)-Norepinephrine (+)-bitartrate salt monohydrate, meets USP testing specifications;1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-,(2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt), monohydrate;(R)-(-)-norepinephrine L-bitartrate monohydrate;HMS3884J12;Norepinephrine bitartrate (USP);Noradrenaline Tartrate Monohydrate;Norepinephrine bitartrate, United States Pharmacopeia (USP) Reference Standard;AKOS015960250;NORADRENALINE TARTRATE (EP MONOGRAPH);UNII-IFY5PE3ZRW;1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt), monohydrate;Norepinephrine (Bitartrate);Levarterenol bitartrate monohydrate;NOREPINEPHRINE BITARTRATE (USP MONOGRAPH);SW219276-1;(2R,3R)-2,3-DIHYDROXYSUCCINIC ACID - 4-((1R)-2-AMINO-1-HYDROXYETHYL)BENZENE-1,2-DIOL (1:1) HYDRATE;1,2-Benzenediol, 4-((1R)-2-amino-1-hydroxyethyl)-, (2R,3R)-2,3-dihydroxybutanedioate hydrate;Noradrenaline Bitartrate,(S);NOREPINEPHRINE BITARTRATE [USP MONOGRAPH];1,2-BENZENEDIOL, 4-((1R)-2-AMINO-1-HYDROXYETHYL)-, (2R,3R)-2,3-DIHYDROXYBUTANEDIOATE (1:1) (SALT), MONOHYDRATE;1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt), monohydrate;Norepinephrine bitartrate [USAN];Binodrenal;SCHEMBL4326582;HMS3656J03;4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; (2R,3R)-2,3-dihydroxybutanedioic acid; hydrate;Noradrenaline bitartrate monohydrate (Levoph;LEVOPHED (TN);Norepinephrine bitartrate hydrate;S2615;108341-18-0;LEVOPHED(R) NOREPINEPHRINE BITARTRATE;(-)-Norepinephrine bitartrate salt monohydrate;1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt), monohydrate;NOREPINEPHRINE BITARTRATE (USP-RS);34888-32-9;(R)-4-(2-amino-1-hydroxyethyl)benzene-;Arterenol, tartrate, monohydrate;A836659;IFY5PE3ZRW;CCG-267878;Norepinephrine Phenolic;Noradrenaline tartrate, European Pharmacopoeia (EP) Reference Standard;AT28911;DTXSID2047806;L-(-)-Norepinephrine (+)-bitartrate salt monohydrate, >=99%, solid;Noradrenaline bitartrate monohydrate;L-Norepinephrine hydrogen L-tartrate monohydrate, >=99.0% (sum of enantiomers, HPLC);Norepinephrine bitartrate [USAN:USP];CHEMBL5087452;J-002120;D05206;Noradrenaline (as tartrate);1,2-diol (2R,3R)-2,3-dihydroxysuccinate hydrate;Norepinephrine (bitartrate monohydrate);NOREPINEPHRINE BITARTRATE [USP-RS];(-)-Noradrenaline bitartrate;4-[(1R)-2-amino-1-hydroxy-ethyl]benzene-1,2-diol; (2R,3R)-2,3-dihydroxybutanedioic acid; hydrate;NOREPINEPHRINE BITAR... |
| CAS No. | 69815-49-2 |
| 分子式 | C12H19NO10 |
| 分子量 | 337.28 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学